Dr. Reddy's Laboratories Ltd. - Research Center
500124 DRREDDY Group (A) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 24 | Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | |
|---|---|---|---|---|---|
| Sales | 12,537.50 | 10,276.00 | 8,510.90 | 7,148.30 | 7,256.90 |
| Operating profit | 4,706.50 | 3,856.80 | 2,382.30 | 1,283.90 | 1,310.20 |
| Interest | 35.50 | 10.30 | 11.50 | 20.40 | 17.60 |
| Gross profit | 5,064.50 | 4,303.20 | 2,892.20 | 1,441.20 | 1,596.90 |
| EPS (Rs) | 39.56 | 33.96 | 19.42 | 9.14 | 10.37 |
Half yearly
results in details
| Sep ' 24 | Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | |
|---|---|---|---|---|---|
| Other income | 393.50 | 456.70 | 521.40 | 177.70 | 304.30 |
| Stock adjustment | -219.10 | -121.70 | 150.80 | -112.30 | -277.30 |
| Raw material | 1,845.40 | 1,565.10 | 1,441.40 | 1,522.70 | 1,543.90 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 1,696.00 | 1,523.90 | 1,359.10 | 1,212.90 | 1,221.70 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | 2,254.60 | 1,085.50 | 2,178.70 |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 4,508.70 | 3,451.90 | 922.70 | 2,145.80 | 1,279.70 |
| Provisions made | - | - | - | 9.80 | - |
| Depreciation | 509.80 | 483.00 | 447.70 | 410.60 | 403.70 |
| Taxation | 1,255.40 | 988.20 | 828.70 | 269.80 | 330.80 |
| Net profit / loss | 3,299.30 | 2,832.00 | 1,615.80 | 760.80 | 862.40 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 83.40 | 83.40 | 83.20 | 83.20 | 83.20 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 37.54 | 37.53 | 27.99 | 17.96 | 18.05 |
| GPM (%) | 39.17 | 40.09 | 32.02 | 19.67 | 21.12 |
| NPM (%) | 25.51 | 26.39 | 17.89 | 10.38 | 11.41 |
© 2025 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis